Oramed Pharmaceuticals In... (ORMP)
Oramed Pharmaceuticals Inc. (ORMP) Stock Price, Analysis & Data
| Geld | 3.14 |
| Marktkapitalisierung | 181.99 Mio |
| Umsatz (TTM) | n/a |
| Nettogewinn (TTM) | 174.06 Mio |
| Beta | 1.16 |
| EPS (ttm) | 4.13 |
| KGV (TTM) | 1.06 |
| Forward-KGV | -54.69 |
| KBV (TTM) | 0.57 |
| KUV (TTM) | n/a |
| Earnings Date | Nov 12, 2026 |
| Brief | 5.55 |
| Volumen | 113,512 |
| Ø Vol. (20D) | 294,750 |
| Eröffnung | 4.35 |
| Vortagesschluss | 4.27 |
| Tagesspanne | 4.30 - 4.45 |
| 52-Wk Range | 1.98 - 5.19 |
| Analyst | n/a |
| Kursziel | 6.25 (42.69%) |
| Dividenden | $0.25 (5.86%) |
| Ex-Dividenden-Datum | 16. Jan. 2026 |
Über ORMP
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporat...
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Oramed Pharmaceuticals 2 Mio, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei 64.05 Mio, ein Rückgang von -436.04 %.
FinanzberichteAnalystenprognose
Laut 1 Analysten-Bewertungen ist die durchschnittliche Einschätzung für die ORMP-Aktie "null". Das 12-Monats-Kursziel liegt bei 6.25, was Aufwärtspotenzial von 42.69% gegenüber dem aktuellen Kurs entspricht.
AktienprognosenGewinnüberraschung
Analysten erwarten einen Umsatz von ... Upgrade
vor 3 Monaten · Simply Wall St.
Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny StocksThe market has climbed 1.5% in the last 7 days and is up 26% over the last 12 months, with earnings forecast to grow by 17% annually. While the term 'penny stock' might seem outdated, these investment...
vor 4 Monaten · Simply Wall St.
Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy InvestorsThe market has shown impressive growth, with a 4.2% increase over the last week and a 29% rise over the past year, while earnings are projected to grow by 16% annually. Although the term 'penny stock'...
